Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

New treatments aim to improve thin endometrium to help more couples with infertility.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Using steroids can increase the risk of heart problems.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Adrenal disorders can cause lasting brain and behavior issues in children.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.